PhD LIVE Study Fair

Oxford | Edinburgh | Sheffield

Coventry University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Reading Featured PhD Programmes
"antibodies"×
10 miles

antibodies PhD Projects, Programs & Scholarships

We have 21 antibodies PhD Projects, Programs & Scholarships

  • "antibodies" ×
  • clear all
Order by 
Showing 1 to 10 of 21
  In silico design of high-affinity recombinant antibodies
  Dr P Mulheran, Dr V A Ferro
Application Deadline: 20 September 2019

Funding Type

PhD Type

Currently there is a trend to move from small drug molecule therapy to use of biologics such as monoclonal antibodies (mAb).
  Generation, characterisation and commercialisation of native-restricted and neoepitope-specific monoclonal antibodies directed against the terminal complement protein C7
  Prof R Würzner, Prof Z Prohaszka
Application Deadline: 10 November 2019

Funding Type

PhD Type

Complement is one of the most important players in innate immune defense. Three activation pathways are triggered by multiple interactions and are amplified in cascades, leading to the activation of the terminal complement (TC) pathway.
  Protein engineering of protein switches for development of diagnostics tools
  Prof Bernd Rehm
Applications accepted all year round

Funding Type

PhD Type

Sensitive and specific detection of serum antibodies is often used to diagnose infections. This project aims to develop a simple qualitative/quantitative device for detection of antibodies of interest.
  Understanding basic biological mechanisms and the development of targeted therapies
  Prof G Bou-Gharios
Applications accepted all year round

Funding Type

PhD Type

The PhD proposal is aimed at understanding some of the fundamental mechanism(s) that control extracellular matrix (ECM) proteins and to develop new technologies and therapeutic based on changes in fibroblast gene expression profiling and surface antibodies during the development of connective tissue fibrosis.
  Development of immunoassays for specific classical and lectin pathway activation markers
  Prof Z Prohaszka, Prof R Würzner
Application Deadline: 10 November 2019

Funding Type

PhD Type

Infections and various immune-inflammation mediated conditions are characterized by the activation of the complement system. Antibodies (immune complexes) activate the classical pathway whereas repetitive carbohydrate structures give rise to the initiation of the lectin pathway.
  New Point of Care Diagnostic Technology for Cancer Biomarkers
  Dr P Mendes
Applications accepted all year round

Funding Type

PhD Type

There is now overwhelming evidence that glycosylation, the process by which sugars are attached to proteins, changes during the development and progression of various malignancies.
  Development of a novel immunotoxin
  Dr L J Partridge
Applications accepted all year round

Funding Type

PhD Type

Immunotoxins represent a form of immunotherapy whereby antibodies are used to target a toxin, usually to cancer or infected host cells.
  Developing an enzymatic toolbox to make complex modified peptides
  Prof M Jaspars, Dr W Houssen, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

The pharmaceutical industry has identified a major gap in its portfolio. On the one hand, they are excellent at discovering small molecules that act via a lock and key type mechanism.
  Discovery of novel pharmaceuticals from marine and desert microorganisms
  Prof M Jaspars, Dr R Ebel
Applications accepted all year round

Funding Type

PhD Type

Microorganisms from extreme environments such as the deep seas, cold seas and hyper arid deserts have been shown to produce a range of complex natural products with high biological activity.
  Formulation of a novel suspending medium for immobilised culture and tissue processing
  Dr L Grover
Application Deadline: 11 December 2019

Funding Type

PhD Type

Bone damage following blast or ballistic wounding results in the mechanic destruction and death of tissue at the site of injury. Surgeons debride away the tissue, removing any necrotic regions and this generally enables complete regeneration of the defect.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.